https://clinicaltrials.novartis.com/clinical-trials/listings/98/study-to-evaluate-the-NCT06751238-5/1https://clinicaltrials.novartis.com/clinical-trials/listings/151/a-phase-iib-dose-ranging-NCT07431177-5/1https://clinicaltrials.novartis.com/clinical-trials/listings/191/a-phase-2-study-NCT07681271-5/1https://clinicaltrials.novartis.com/clinical-trials/listings/193/two-arm-double-blind-phase-NCT07621809-5/?featured=true1https://clinicaltrials.novartis.com/clinical-trials/listings/194/a-study-to-evaluate-NCT07700056-5/1https://clinicaltrials.novartis.com/clinical-trials/listings/195/a-phase-2ab-study-NCT07737743-5/?featured=true1https://clinicaltrials.novartis.com/clinical-trials/listings/201/a-study-to-assess-NCT07775924-5/?featured=true1https://clinicaltrials.novartis.com/clinical-trials/listings/204/a-52-week-study-of-NCT07768371-5/1https://clinicaltrials.novartis.com/clinical-trials/listings/205/a-study-to-assess-NCT07801495-5/?featured=true1https://clinicaltrials.novartis.com/clinical-trials/listings/207/a-study-to-evaluate-NCT07811869-5/1